Business Wire

MHW Ltd. Rolls Out Significant International Expansion – Innovative Service Platform Facilitates Beverage Alcohol Exports to Europe

Jaa

MHW, Ltd., the leading service provider for wine, beer, cider and spirits in the U.S., has announced a significant international business expansion. Effective immediately, the company will offer U.S. and international beverage alcohol companies a model to build their export business to Europe, with other world regions to follow. As part of their global expansion, MHW has also announced that craft spirits leader, Templeton Rye, will be the first major brand distributed to European markets through their new service platform.

“We are delighted that Templeton Rye, an industry leader, chose MHW to efficiently realize their export goals through one seamless business solution that maximizes brand control and market opportunity from day one,” says Gabe Barkley, Chief Executive Officer of MHW, Ltd.

John Beaudette, President of MHW, Ltd. continues, “There is a growing demand for U.S. craft products in Europe that we are now able to serve with a depth of distribution and reach that has been previously unavailable to producers without substantial investment. Our goal is to become a trusted advisor for brands looking to enter European markets by leveraging the practices that have driven decades of success in the U.S.”

Since 1995, MHW has consistently paved the way in uncovering new opportunities and designing innovative business solutions. MHW, a nationally licensed importer and distributor, serves over 350 wine, spirits and beer clients in the U.S. sourced from over 80 different countries, representing annual volumes between 100 and 1,000,000 cases sold. The key aspects of MHW’s European service leverage decades of operational expertise, including: (1) a seamless transition for brands looking to grow their exports; (2) a cost-effective model for market entry that can be customized to one or many countries; and (3) the ability to build a European business infrastructure with one single service provider and no back office employee overhead.

“Templeton Rye is delighted to enter European markets for the first time in partnership with MHW,” says Shane Fitzharris, Executive Vice President of Global Sales for Templeton Rye. “We’re seeing unprecedented demand for Templeton Rye Whiskey internationally and we’re able to focus on brand-building for our European consumers while MHW facilitates the critical operational support we need to succeed.” In addition to their European agreement with MHW, Templeton Rye has also recently started exporting to Japan, New Zealand, South Korea and India with further plans to increase their international footprint in 2018 and 2019. The implementation of a global roll-out of the brand is supported by the opening of their new $35-million Templeton whiskey distillery in Iowa in August 2018.

The MHW European platform will operate through a logistics hub in the Netherlands with additional expertise in the United Kingdom, and turnkey back-office support from over 100 professionals based in New York. Services include: compliance and European legislation consulting; customer service; operations support; and accounting, all supported by a best-in-class technology suite providing real-time business intelligence to clients.

For more information, including management team interviews, please contact: Helen Gregory, helen@gregoryvine.com, and Natasja Mallory, natasja@gregoryvine.com.

ABOUT MHW, Ltd.

MHW, Ltd. is a nationally-licensed beverage alcohol importer, distributor, and service provider, leading the industry since 1934. With licenses in all 50 states, MHW is the preferred partner for established and aspiring brands in wine, spirits, and beer. MHW works with suppliers in over 80 countries, providing operations, logistics, compliance, sales distribution, marketing and new brand development for their clients. For more information, visit www.mhwltd.com.

ABOUT TEMPLETON RYE

Templeton Rye Whiskey tracks back to the early 1920s when residents of Templeton distilled a much sought-after rye whiskey. That bootlegging enterprise, forced underground during the Prohibition era, nonetheless flourished during that period. Today, the whiskey may be slightly different—instead of stills in basements and barns, the company has a modern, legal plant—but the entrepreneurial spirit remains true to Templeton’s roots. On August 7, 2018, Templeton Rye Spirits, LLC marked the beginning of a new chapter, highlighting a rich history with the community they call home by the official opening of the Templeton Distillery in Iowa. The 34,500 square-foot distillery, a $35 million project, was a significant investment in the community of Templeton.

Templeton Distillery Snapshot

  • 55,000 square-foot barrel aging warehouse that can store up to 54,000 barrels
  • Located on 20-acres of land just east of downtown Templeton
  • Produces up to 500,000 proof gallons of rye whiskey annually
  • Features stills imported from Scotland to produce the highest quality spirits
  • 28 employees, up 17 positions from previous staffing needs
  • Includes museum, visitor center and tasting room

Contact information

Helen Gregory
helen@gregoryvine.com
or
Natasja Mallory
natasja@gregoryvine.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 13:49Tiedote

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41Tiedote

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42Tiedote

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00Tiedote

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme